Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$95,765,809
-$71,686,457 QoQ
Shares Held
1,332,672
-5.9% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#59
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $96,941,137 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (98.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,332,672 | $95,765,809 | |
| 2 | VTRS |
Viatris Inc
|
50,553 | $802,781 | |
| 3 | HLN |
Haleon plc
|
16,242 | $151,537 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
9,333 | $149,607 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
40 | $21,673 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
1,000 | $14,490 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
384 | $13,009 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
187 | $8,697 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,765,809 | 1,332,672 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $167,452,266 | 1,416,566 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $210,146,199 | 1,670,213 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $274,368,436 | 1,875,126 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $299,191,790 | 1,918,511 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $317,244,162 | 1,926,779 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $317,177,134 | 1,946,708 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $393,387,274 | 2,013,447 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $354,064,743 | 2,042,367 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $350,181,956 | 2,069,511 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $414,959,372 | 2,102,444 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $370,649,601 | 2,130,415 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $373,339,569 | 2,167,932 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $370,578,160 | 2,226,497 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $331,182,922 | 2,259,863 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $343,594,158 | 2,317,042 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $397,715,472 | 2,313,779 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $436,591,319 | 2,315,029 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $710,777,395 | 2,912,664 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $573,866,579 | 2,955,942 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $567,091,057 | 3,042,987 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $493,192,399 | 3,131,778 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $577,119,684 | 3,487,128 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $599,671,639 | 3,626,242 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $527,771,599 | 3,851,223 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $469,215,789 | 3,986,879 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||